{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T18:26:26Z","timestamp":1771266386795,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1007\/s00384-007-0370-3","type":"journal-article","created":{"date-parts":[[2007,8,16]],"date-time":"2007-08-16T08:16:38Z","timestamp":1187252198000},"page":"1421-1427","source":"Crossref","is-referenced-by-count":68,"title":["The proinflammatory CXC-chemokines GRO-\u03b1\/CXCL1 and MIG\/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids"],"prefix":"10.1007","volume":"22","author":[{"given":"Arne","family":"Egesten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mette","family":"Eliasson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders I.","family":"Olin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas S.","family":"Erjef\u00e4lt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Bjartell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Sangfelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,12,1]]},"reference":[{"key":"370_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMra020831","volume":"347","author":"DK Podolsky","year":"2002","unstructured":"Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417\u2013429","journal-title":"N Engl J Med"},{"key":"370_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1155\/1998\/398384","volume":"12","author":"SN Elliott","year":"1998","unstructured":"Elliott SN, Wallace JL (1998) Neutrophil-mediated gastrointestinal injury. Can J Gastroenterol 12:559\u2013568","journal-title":"Can J Gastroenterol"},{"key":"370_CR3","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1080\/003655202760373308","volume":"37","author":"A Egesten","year":"2002","unstructured":"Egesten A, Andersson P, Persson T (2002) Eosinophils in gastrointestinal inflammation: from innocent bystanders to offenders. Scand J Gastroenterol 37:1117\u20131125","journal-title":"Scand J Gastroenterol"},{"key":"370_CR4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00054725-199811000-00005","volume":"4","author":"L Camoglio","year":"1998","unstructured":"Camoglio L, Te Velde AA, Tigges AJ, Das PK, Van Deventer SJ (1998) Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis 4:285\u2013290","journal-title":"Inflamm Bowel Dis"},{"key":"370_CR5","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1172\/JCI19836","volume":"113","author":"IJ Fuss","year":"2004","unstructured":"Fuss IJ, Heller F, Boirivant M, Leon F, Yoshida M, Fichtner-Feigl S, Yang Z, Exley M, Kitani A, Blumberg RS, Mannon P, Strober W (2004) Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest 113:1490\u20131497","journal-title":"J Clin Invest"},{"key":"370_CR6","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1046\/j.1365-2796.2001.00867.x","volume":"250","author":"M Baggiolini","year":"2001","unstructured":"Baggiolini M (2001) Chemokines in pathology and medicine. J Intern Med 250:91\u2013104","journal-title":"J Intern Med"},{"key":"370_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1053\/gast.2001.21403","volume":"120","author":"AD Luster","year":"2001","unstructured":"Luster AD (2001) Chemokines regulate lymphocyte homing to the intestinal mucosa. Gastroenterology 120:291\u2013294","journal-title":"Gastroenterology"},{"key":"370_CR8","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1002\/j.1460-2075.1989.tb03569.x","volume":"8","author":"DZ Wen","year":"1989","unstructured":"Wen DZ, Rowland A, Derynck R (1989) Expression and secretion of gro\/MGSA by stimulated human endothelial cells. EMBO J 8:1761\u20131766","journal-title":"EMBO J"},{"key":"370_CR9","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.4049\/jimmunol.162.6.3549","volume":"162","author":"A Sauty","year":"1999","unstructured":"Sauty A, Dziejman M, Taha RA, Iarossi AS, Neote K, Garcia-Zepeda EA, Hamid Q, Luster AD (1999) The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol 162:3549\u20133558","journal-title":"J Immunol"},{"key":"370_CR10","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.4049\/jimmunol.170.10.5309","volume":"170","author":"T Persson-Dajotoy","year":"2003","unstructured":"Persson-Dajotoy T, Andersson P, Bjartell A, Calafat J, Egesten A (2003) Expression and production of the CXC chemokine growth-related oncogene-alpha by human eosinophils. J Immunol 170:5309\u20135316","journal-title":"J Immunol"},{"key":"370_CR11","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.4049\/jimmunol.165.3.1548","volume":"165","author":"T Jinquan","year":"2000","unstructured":"Jinquan T, Jing C, Jacobi HH, Reimert CM, Millner A, Quan S, Hansen JB, Dissing S, Malling HJ, Skov PS, Poulsen LK (2000) CXCR3 expression and activation of eosinophils: role of IFN-gamma-inducible protein-10 and monokine induced by IFN-gamma. J Immunol 165:1548\u20131556","journal-title":"J Immunol"},{"key":"370_CR12","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.4049\/jimmunol.165.9.5269","volume":"165","author":"CL Addison","year":"2000","unstructured":"Addison CL, Daniel TO, Burdick MD, Liu H, Ehlert JE, Xue YY, Buechi L, Walz A, Richmond A, Strieter RM (2000) The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol 165:5269\u20135277","journal-title":"J Immunol"},{"key":"370_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1172\/JCI9775","volume":"107","author":"P Romagnani","year":"2001","unstructured":"Romagnani P, Annunziato F, Lasagni L, Lazzeri E, Beltrame C, Francalanci M, Uguccioni M, Galli G, Cosmi L, Maurenzig L, Baggiolini M, Maggi E, Romagnani S, Serio M (2001) Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest 107:53\u201363","journal-title":"J Clin Invest"},{"key":"370_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.4049\/jimmunol.167.2.623","volume":"167","author":"AM Cole","year":"2001","unstructured":"Cole AM, Ganz T, Liese AM, Burdick MD, Liu L, Strieter RM (2001) IFN-inducible ELR\u2212 CXC chemokines display defensin-like antimicrobial activity. J Immunol 167:623\u2013627","journal-title":"J Immunol"},{"key":"370_CR15","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","volume":"323","author":"A Ekbom","year":"1990","unstructured":"Ekbom A, Helmick C, Zack M, Adami HO (1990) Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323:1228\u20131233","journal-title":"N Engl J Med"},{"key":"370_CR16","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1572-0241.2001.03743.x","volume":"96","author":"P Sangfelt","year":"2001","unstructured":"Sangfelt P, Carlson M, Thorn M, L\u00f6\u00f6f L, Raab Y (2001) Neutrophil and eosinophil granule proteins as markers of response to local prednisolone treatment in distal ulcerative colitis and proctitis. Am J Gastroenterol 96:1085\u20131090","journal-title":"Am J Gastroenterol"},{"key":"370_CR17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/00365521.1970.12096647","volume":"5","author":"V Binder","year":"1979","unstructured":"Binder V (1979) A comparison between clinical state, macroscopic and microscopic appearances of rectal mucosa, and cytologic picture of mucosal exudate in ulcerative colitis. Scand J Gastroenterol 5:627\u2013632","journal-title":"Scand J Gastroenterol"},{"key":"370_CR18","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1136\/bmj.1.4979.1315","volume":"1","author":"SC Truelove","year":"1956","unstructured":"Truelove SC, Richards WC (1956) Biopsy studies in ulcerative colitis. Br Med J 1:1315\u201313188","journal-title":"Br Med J"},{"key":"370_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/32.2.6198355","volume":"32","author":"JL Cordell","year":"1984","unstructured":"Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219\u2013229","journal-title":"J Histochem Cytochem"},{"key":"370_CR20","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1023\/A:1019681030784","volume":"47","author":"P Sangfelt","year":"2002","unstructured":"Sangfelt P, Carlson M, Thorn M, Xu S, Loof L, Raab Y (2002) Local release of human neutrophil lipocalin (HNL), IL-8, and TNF-alpha is decreased as response to topical prednisolone treatment in distal ulcerative colitis and proctitis. Dig Dis Sci 47:2064\u20132069","journal-title":"Dig Dis Sci"},{"key":"370_CR21","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1572-0241.1999.00940.x","volume":"94","author":"A Keshavarzian","year":"1999","unstructured":"Keshavarzian A, Fusunyan RD, Jacyno M, Winship D, MacDermott RP, Sanderson IR (1999) Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am J Gastroenterol 94:704\u2013712","journal-title":"Am J Gastroenterol"},{"key":"370_CR22","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0002-9440(10)65128-0","volume":"155","author":"M Uguccioni","year":"1999","unstructured":"Uguccioni M, Gionchetti P, Robbiani DF, Rizzello F, Peruzzo S, Campieri M, Baggiolini M (1999) Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol 155:331\u2013336","journal-title":"Am J Pathol"},{"key":"370_CR23","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood.V89.10.3503","volume":"89","author":"N Borregaard","year":"1997","unstructured":"Borregaard N, Cowland JB (1997) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89:3503\u20133521","journal-title":"Blood"},{"key":"370_CR24","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1086\/510857","volume":"195","author":"A Egesten","year":"2007","unstructured":"Egesten A, Eliasson M, Johansson HM, Olin AI, M\u00f6rgelin M, Mueller A, Pease JE, Frick IM, Bj\u00f6rck L (2007) The CXC chemokine MIG\/CXCL9 is important in innate immunity against Streptococcus pyogenes. J Infect Dis 195:684\u2013693","journal-title":"J Infect Dis"},{"key":"370_CR25","doi-asserted-by":"crossref","first-page":"16283","DOI":"10.1016\/S0021-9258(18)41997-7","volume":"267","author":"J Lee","year":"1992","unstructured":"Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI (1992) Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 267:16283\u201316287","journal-title":"J Biol Chem"},{"key":"370_CR26","doi-asserted-by":"publisher","first-page":"20545","DOI":"10.1074\/jbc.271.34.20545","volume":"271","author":"SK Ahuja","year":"1996","unstructured":"Ahuja SK, Murphy PM (1996) The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 271:20545\u201320550","journal-title":"J Biol Chem"},{"key":"370_CR27","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1038\/sj.onc.1203687","volume":"19","author":"E Loukinova","year":"2000","unstructured":"Loukinova E, Dong G, Enamorado-Ayalya I, Thomas GR, Chen Z, Schreiber H, Van Waes C (2000) Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene 19:3477\u20133486","journal-title":"Oncogene"},{"key":"370_CR28","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.4049\/jimmunol.172.5.2853","volume":"172","author":"MP Keane","year":"2004","unstructured":"Keane MP, Belperio JA, Xue YY, Burdick MD, Strieter RM (2004) Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol 172:2853\u20132860","journal-title":"J Immunol"},{"key":"370_CR29","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.4049\/jimmunol.176.3.1456","volume":"176","author":"J Pan","year":"2006","unstructured":"Pan J, Burdick MD, Belperio JA, Xue YY, Gerard C, Sharma S, Dubinett SM, Strieter RM (2006) CXCR3\/CXCR3 ligand biological axis impairs RENCA tumor growth by a mechanism of immunoangiostasis. J Immunol 176:1456\u20131464","journal-title":"J Immunol"},{"key":"370_CR30","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1172\/JCI28349","volume":"116","author":"KS Lang","year":"2006","unstructured":"Lang KS, Georgiev P, Recher M, Navarini AA, Bergthaler A, Heikenwalder M, Harris NL, Junt T, Odermatt B, Clavien PA, Pircher H, Akira S, Hengartner H, Zinkernagel RM (2006) Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling. J Clin Invest 116:2456\u20132463","journal-title":"J Clin Invest"},{"key":"370_CR31","doi-asserted-by":"publisher","first-page":"6435","DOI":"10.4049\/jimmunol.169.11.6435","volume":"169","author":"PL Podolin","year":"2002","unstructured":"Podolin PL, Bolognese BJ, Foley JJ, Schmidt DB, Buckley PT, Widdowson KL, Jin Q, White JR, Lee JM, Goodman RB, Hagen TR, Kajikawa O, Marshall LA, Hay DW, Sarau HM (2002) A potent and selective nonpeptide antagonist of CXCR2 inhibits acute and chronic models of arthritis in the rabbit. J Immunol 169:6435\u20136444","journal-title":"J Immunol"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-007-0370-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00384-007-0370-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-007-0370-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-007-0370-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T20:20:29Z","timestamp":1684009229000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00384-007-0370-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["370"],"URL":"https:\/\/doi.org\/10.1007\/s00384-007-0370-3","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}